Terms: = Lung cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3
11 results:
1. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
[TBL] [Abstract] [Full Text] [Related]
2. Deep learning-based internal gross target volume definition in 4D CT images of lung cancer patients.
Ma Y; Mao J; Liu X; Dai Z; Zhang H; Zhang X; Li Q
Med Phys; 2023 Apr; 50(4):2303-2316. PubMed ID: 36398404
[TBL] [Abstract] [Full Text] [Related]
3. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of lung Adenocarcinoma.
Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
Front Immunol; 2021; 12():728853. PubMed ID: 35140701
[TBL] [Abstract] [Full Text] [Related]
4. Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease.
Shimura K; Shibata H; Mizuno Y; Amano N; Hoshino K; Kuroda T; Kameyama K; Matsuse M; Mitsutake N; Sugino K; Yoshimura Noh J; Hasegawa T; Ishii T
Horm Res Paediatr; 2019; 91(3):210-215. PubMed ID: 30092570
[TBL] [Abstract] [Full Text] [Related]
5. A somatic tshr mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
Kim JW; Lee S; Lui N; Choi H; Mulvihill M; Fang LT; Kang HC; Kwon YW; Jablons D; Kim IJ
Oncol Rep; 2012 Oct; 28(4):1225-30. PubMed ID: 22842620
[TBL] [Abstract] [Full Text] [Related]
6. [Abnormal uptake of l-131 in the lung in a patient with thyroid cancer: is it metastasis or not?].
Guijarro de Armas G; Elviro Peña R; Monereo Megías S; Montaño Martínez JM
Rev Clin Esp; 2011 Apr; 211(4):194-8. PubMed ID: 21420668
[TBL] [Abstract] [Full Text] [Related]
7. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.
Franco AT; Malaguarnera R; Refetoff S; Liao XH; Lundsmith E; Kimura S; Pritchard C; Marais R; Davies TF; Weinstein LS; Chen M; Rosen N; Ghossein R; Knauf JA; Fagin JA
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1615-20. PubMed ID: 21220306
[TBL] [Abstract] [Full Text] [Related]
8. Fatal outcome of a young woman with papillary thyroid carcinoma and graves' disease: possible implication of "cross-signalling" mechanism.
Cross GA; Suarez H; Pitoia F; Moncet D; Vanegas M; Bruno OD; Niepomniszcze H
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1194-200. PubMed ID: 19082310
[TBL] [Abstract] [Full Text] [Related]
9. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases.
Führer D; Tannapfel A; Sabri O; Lamesch P; Paschke R
Endocr Relat Cancer; 2003 Dec; 10(4):591-600. PubMed ID: 14713269
[TBL] [Abstract] [Full Text] [Related]
10. [Hyperfunctioning thyroid carcinoma. Description of a case].
Pandolfi C; Colecchia M; Gianini A
Minerva Endocrinol; 1997 Sep; 22(3):79-82. PubMed ID: 9557475
[TBL] [Abstract] [Full Text] [Related]
11. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
[TBL] [Abstract] [Full Text] [Related]
